HomeInsightsPE

Samrat Pharmachem Ltd P/E Ratio

Samrat Pharmachem Ltd P/E Ratio

download
stocks purchased

₹ 0.6 Cr

Volume transacted

stocks purchased

17.1 K

stocks traded

Last Updated time: 18 Jul 9.00 AM

Image

Samrat Pharmachem Ltd

NSE: SAMRATPHARMA

PE

51

Last updated : 18 Jul 9.00 AM

Key Highlights

    The P/E Ratio of Samrat Pharmachem Ltd is 51 as of 18 Jul 9.00 AM .a1#The P/E Ratio of Samrat Pharmachem Ltd changed from 15 on March 2019 to 6.9 on March 2023 . This represents a CAGR of -14.38% over 5 years. a1#The Latest Trading Price of Samrat Pharmachem Ltd is ₹ 356.9 as of 18 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.2 in 5 years. This represents a CAGR of -0.93%a1# The PE Ratio of Automobile industry is 18.5. The PE Ratio of Finance industry is 24.5. The PE Ratio of IT - Software industry is 29.3. The PE Ratio of Pharmaceuticals industry is 36.7. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 20.5. In 2024a1#The Market Cap of Samrat Pharmachem Ltd changed from ₹ 23.07 crore on March 2019 to ₹ 114.67 crore on March 2023 . This represents a CAGR of 37.81% over 5 years. a1#The Revenue of Samrat Pharmachem Ltd changed from ₹ 86.53 crore to ₹ 82.98 crore over 8 quarters. This represents a CAGR of -2.07% a1#The EBITDA of Samrat Pharmachem Ltd changed from ₹ 12.91 crore to ₹ 1.65 crore over 8 quarters. This represents a CAGR of -64.25% a1#The Net Pr of Samrat Pharmachem Ltd changed from ₹ 9.37 crore to ₹ 1.4 crore over 8 quarters. This represents a CAGR of -61.35% a1#The Dividend Payout of Samrat Pharmachem Ltd changed from 1.8 % on March 2019 to 1.86 % on March 2023 . This represents a CAGR of 1.65% over 2 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Samrat Pharmachem Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Samrat Pharmachem Ltd

Period
Mar '1915
Mar '204.4
Mar '217.9
Mar '228.7
Mar '236.9

Company Fundamentals for Samrat Pharmachem Ltd

Market Cap

110 Cr

EPS

7.0

P/E Ratio (TTM) *

51.0

P/B Ratio (TTM) *

1.7

Day’s High

359.0

Day’s Low

345.0

DTE *

0.1

ROE *

3.3

52 Week High

473.0

52 Week Low

320.0

ROCE *

4.4

* All values are consolidated

Last Updated time: 18 Jul 9.00 AM

* All values are consolidated

Last Updated time: 18 Jul 9.00 AM

Image

Samrat Pharmachem Ltd

NSE: SAMRATPHARMA

PRICE

356.9

19.80 (5.87%)

stock direction

Last updated : 18 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

Asset Value vs Market Value of Samrat Pharmachem Ltd

Market Value

110

Asset Value

99

0.1 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Samrat Pharmachem Ltd50110
Sun Pharmaceuticals Industries Ltd38382,370
Divis Laboratories Ltd75121,646
Cipla Ltd28121,616
Zydus Lifesciences Ltd30119,269
Dr Reddys Laboratories Ltd20111,194

Key Valuation Metric of Samrat Pharmachem Ltd

Earnings

2 Cr

51.0 X

PE Ratio

Market Cap

₹110.28Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

2 Cr

51.0 X

PE Ratio

Market Cap

₹110.28Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Samrat Pharmachem Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Samrat Pharmachem Ltd

Period
Mar '1923
Mar '2019
Mar '2142
Mar '22150
Mar '23115

* All values are a in crore

×

Historical Revenue of Samrat Pharmachem Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Samrat Pharmachem Ltd

Period
Jun '2287
Sep '2271
Dec '2284
Mar '2369
Jun '2358
Sep '2380
Dec '2362
Mar '2483

* All values are a in crore

×

Historical EBITDA of Samrat Pharmachem Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Samrat Pharmachem Ltd

Period
Jun '2213
Sep '228
Dec '224
Mar '230
Jun '231
Sep '231
Dec '231
Mar '242

* All values are a in crore

×

Historical Net Profit of Samrat Pharmachem Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Samrat Pharmachem Ltd

Period
Jun '229
Sep '226
Dec '222
Mar '23-1
Jun '231
Sep '230
Dec '230
Mar '241

* All values are a in crore

×

Historical Dividend Payout of Samrat Pharmachem Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Samrat Pharmachem Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '222
Mar '232

* All values are a in %

About Samrat Pharmachem Ltd

About Samrat Pharmachem Ltd

    Samrat Pharmachem Ltd was incorporated on June 16, 1992. The Company's principal activities are manufacturing and selling chemicals. The Company floated a new 100% subsidiary company during the year 2003-04 named as Samrat Remedies Limited to carry on activities of Manufacturing of Pharmaceutical Bulk Drugs & Chemicals.

Samrat Pharmachem Ltd News Hub

News

Samrat Pharmachem to declare Quarterly Result

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 13 Augus...

Read more

29 Jun 202417:37

News

Samrat Pharmachem AGM scheduled

Samrat Pharmachem announced that the 32th Annual General Meeting (AGM) of the company will...

Read more

28 Jun 202418:50

News

Board of Samrat Pharmachem recommends final dividend

Samrat Pharmachem announced that the Board of Directors of the Company at its meeting held...

Read more

31 May 202410:37

News

Samrat Pharmachem to discuss results

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 30 May 2...

Read more

29 Mar 202410:06

News

Samrat Pharmachem announces board meeting date

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 Febru...

Read more

30 Dec 202309:56

News

Samrat Pharmachem to hold board meeting

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 8 Novemb...

Read more

27 Sep 202311:19

Product Composition by Percentage (Revenue)

FAQs for PE of Samrat Pharmachem Ltd

What is Samrat Pharmachem Ltd current share price?

The current market price of Samrat Pharmachem Ltd as of July 18, 2024 is ₹356.90.

What is Samrat Pharmachem Ltd's market cap?

Samrat Pharmachem Ltd's market capitalisation stood at ₹110 Cr as of July 18, 2024

What are Samrat Pharmachem Ltd's total net assets?

According to Samrat Pharmachem Ltd's most recent financial filings, the company's net assets total ₹99.0 Cr.

Is Samrat Pharmachem Ltd making a profit or loss?

Samrat Pharmachem Ltd's net Profit as of July 18, 2024 is close to ₹2 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199